At a glance
- Originator Takeda
- Class
- Mechanism of Action Endothelin A receptor antagonists; Endothelin B receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Liver disorders; Myocardial infarction; Renal failure; Subarachnoid haemorrhage
Most Recent Events
- 13 Oct 2000 Discontinued-II for Liver disorders in Japan (Unknown route)
- 13 Oct 2000 Discontinued-II for Myocardial infarction in Japan (Injection)
- 13 Oct 2000 Discontinued-II for Renal failure in Europe (Unknown route)